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ABSTRACT
N-acylethanolamines (NAEs) are membrane-derived lipids that are utilised as signalling 
molecules in the nervous system (e.g. the endocannabinoid anandamide). A N-Acyl 
Phosphatidylethanolamine Phospholipase D (NAPE-PLD) that catalyses formation of 
NAEs was recently identified as a member of the zinc metallohydrolase family of 
enzymes. NAPE-PLD-/- mice have greatly reduced brain levels of long-chain saturated 
NAEs, but wild-type levels of polyunsaturated NAEs (e.g. anandamide), suggesting an 
important role for NAPE-PLD in biosynthesis of at least a subset of endogenous NAEs 
in the mammalian nervous system. To provide a neuroanatomical basis for investigation 
of NAPE-PLD function, here we have analysed expression of NAPE-PLD in the mouse 
brain using mRNA in situ hybridisation and immunocytochemistry. NAPE-PLD-/- mice 
were utilised to establish the specificity of probes/antibodies used. The most striking 
feature of NAPE-PLD expression in the brain was in the dentate gyrus, where a strong 
mRNA signal was detected in granule cells. Accordingly, immunocytochemical analysis 
revealed intense NAPE-PLD immunoreactivity in the axons of granule cells (mossy 
fibres). Intense NAPE-PLD immunoreactivity was also detected in axons of the 
vomeronasal nerve that project to the accessory olfactory bulb. NAPE-PLD expression 
was detected in other brain regions (e.g. hippocampus, cortex, thalamus, 
hypothalamus), but the intensity of immunostaining was weaker than in mossy fibres. 
Collectively, the data obtained indicate that NAPE-PLD is expressed by specific 
populations of neurons in the brain and targeted to axonal processes. We suggest that 
NAEs generated by NAPE-PLD in axons may act as anterograde synaptic signalling 
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molecules that regulate the activity of post-synaptic neurons.
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N-acylethanolamines (NAEs) are a class of lipids that are utilised as signalling 
molecules in the nervous system and other tissues/organs (Schmid, 2000; Schmid et al., 
1990). Probably the most widely known NAE is N-arachidonoyl ethanolamine or 
“anandamide”, which is an endogenous ligand for CB1 cannabinoid receptors in the 
central nervous system (Devane et al., 1992). Other physiologically active NAEs include 
the anti-inflammatory lipid N-palmitoyl ethanolamine (PEA) and the appetite-
suppressing substance N-oleoyl ethanolamine (OEA) (Calignano et al., 1998; Jaggar et 
al., 1998; Lambert et al., 2002; Rodriguez de Fonseca et al., 2001).
The discovery of anandamide as an endocannabinoid has stimulated interest in the 
mechanisms of biosynthesis of NAEs in mammals.  NAE biosynthesis has been 
proposed to occur via a two-step enzymatic process. First, a Ca2+-activated N-
acyltransferase transfers the sn-1 acyl chain of a phospholipid onto the amine of 
phosphatidylethanolamine (PE) to generate an N-acyl PE (NAPE). Then NAPE is 
converted by a phospholipase D (PLD) into an NAE and phosphatidic acid (Cadas et al., 
1996; Schmid, 2000; Schmid et al., 1990). A Ca2+-independent N-acyltransferase that is 
highly expressed in testis has been discovered recently (Jin et al., 2007) but the molecular 
identity of a Ca2+-activated N-acyltransferase is currently unknown. However, a N-Acyl 
Phosphatidylethanolamine Phospholipase D (NAPE-PLD) that is expressed in the brain 
has been identified (Okamoto et al., 2004). NAPE-PLD is a 396 amino-acid residue 
protein in mouse and rat and a member of the zinc metallohydrolase family with a -
lactamase fold. Analysis of the occurrence of NAPE-PLD mRNA/protein in mouse 
organs/tissues revealed widespread expression but with particularly high levels in 
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brain and testis, consistent with the distribution of NAPE-PLD enzymatic activity 
(Okamoto et al., 2004).
Recently, “knockout” mice with the NAPE-PLD gene deleted have been generated 
to investigate the in vivo contribution of NAPE-PLD to NAE biosynthesis (Leung et al., 
2006). Consistent with its proposed role in biosynthesis of NAEs, in brain tissue from 
NAPE-PLD-/- mice there was a five-fold reduction in Ca2+-dependent conversion of 
NAPEs to NAEs, comprising both saturated and polyunsaturated N-acyl chains. 
However, when the levels of NAEs in NAPE-PLD-/- mice were compared with wild-type 
littermates, it was found that there was a reduction in NAEs with saturated N-acyl 
chains but no reduction in NAEs with polyunsaturated N-acyl chains, including 
anandamide. Moreover, the most significant reductions were observed for longer NAEs 
comprising saturated N-acyl chains with twenty or more carbon atoms. Collectively, 
these data indicate that NAPE-PLD is the principal biosynthetic enzyme for long-chain 
saturated NAEs, but additional enzymatic pathways are likely to contribute to the 
production of anandamide. Consistent with this premise, a NAPE-PLD-independent 
pathway for NAE biosynthesis has been postulated wherein de-acylation of the O-acyl 
chains of NAPEs leads to formation of lysoNAPEs and then glycerol-3-phosphate-NAEs 
(GP-NAEs), which are then converted to NAEs by phosphodiesterase-mediated 
cleavage of glycerol-3-phosphate (Natarajan et al., 1984).  Recently, a (lyso)NAPE lipase 
that catalyses conversion of NAPEs to GP-NAEs has been purified and identified as ,-
hydrolase-4 (Abhd4) (Simon and Cravatt, 2006).
Another biosynthetic pathway for anandamide has also been characterized in 
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which phospholipase C catalysed cleavage of NAPE generates phosphoanandamide, 
which is then dephosphorylated by phosphatases to generate anandamide (Liu et al., 
2006). Analysis of enzymes involved in lipopolysaccharide (LPS)-induced anandamide 
production in macrophages has led to the identification of a phosphatase (PTPN22) as a 
candidate enzyme in this biosynthetic pathway for anandamide. PTPN22 is also 
expressed in the brain and in PTPNN22-/- mice enzymatic conversion of 
phosphoanandamide to anandamide by brain extracts is reduced by comparison with 
wild-type mice. Therefore, PTPNN22 may contribute to anandamide biosynthesis in the 
brain and other organs/tissues (Liu et al., 2006).
Our ability to ascribe specific functions to different NAE biosynthetic enzymes is 
hindered by our limited understanding of their cellular and subcellular distribution in 
the nervous system and peripheral tissues. A deeper appreciation of the 
neurophysiological roles of NAPE-PLD would be facilitated by knowledge of its 
distribution in the brain and in particular which cell types express this enzyme. A 
preliminary analysis of the regional distribution of NAPE-PLD expression in the rat 
brain using Western blotting methods and real-time PCR revealed that it is widely 
distributed but with the highest level of expression in the thalamus (Morishita et al., 
2005). However, nothing is known about the identity of cells expressing NAPE-PLD in 
the brain. Therefore, here we have used mRNA in situ hybridisation methods to analyse 
the distribution of NAPE-PLD mRNA expression in serial sections of the mouse brain, 
using NAPE-PLD-/- mice to validate the selectivity of the probes used. Furthermore, we 
have developed novel antibodies to the C-terminal region of mouse NAPE-PLD to 
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investigate the distribution of the NAPE-PLD protein in the brain and its location in 
cells expressing the NAPE-PLD gene. NAPE-PLD-/- mice were used to validate the 
specificity of the immunostaining observed in wild-type mouse brain. The data 
presented here provide the first detailed analysis of the distribution of NAPE-PLD 
expression in the brain and a basis for further investigation of the physiological roles of 
NAPE-PLD in brain function.
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MATERIALS AND METHODS
NAPE-PLD mRNA in situ hybridisation
Mouse NAPE-PLD cDNA was sub-cloned from a pcDNA3.1(-) vector into 
pBlueScript SK(+) vector, having established that double-digestion with KpnI and ApaI 
liberated cDNA inserts. Then digoxygenin (DIG)-labelled antisense and sense RNA 
probes for NAPE-PLD mRNA were generated using DIG RNA labelling mix (Roche 
Applied Science, Burgess Hill, UK) and T3 and T7 RNA polymerases (Promega, 
Southampton, UK; NEB, Hitchin, UK).
Mouse brains dissected from mice perfused with 4% paraformaldehyde (PFA) in 
phosphate buffered saline (PBS; pH 7.4) were embedded in paraffin wax and serial 
sections (8 – 10 µm) were cut using a Leica RM 2146 microtome and mounted on 
Superfrost Plus Micro Slides (VWR, Lutterworth, UK). Following hydration, slides were 
incubated with proteinase K (20 µg/ml in a buffer comprising 100 mM Tris HCl, pH 7.5; 
150 mM NaCl; 0.1% Tween 20) for 20 min at room temperature. Sections were post-fixed 
with 4% PFA in PBS for 20 min at room temperature and washed in 5 X SSC buffer (20 X 
SSC = 3 M NaCl, 0.3 M Na3C6H5O7, pH 6.0) followed by 5 X SSC buffer with 0.1% Tween 
20 added. Then sections were incubated for 2 h at 60oC with hybridisation buffer (50 % 
formamide in 5 X SSC, 50 µg/ml yeast RNA, 50 µg/ml heparin, 0.1 % Tween 20; 300 µl 
per slide). Hybridisation was performed overnight at 60oC in hybridisation buffer 
containing 800 ng/ml of antisense or sense probes (150 µl per slide covered by a 
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Parafilm “M” coverslip). Parafilm coverslips were floated off in 5 X SSC buffer and then 
slides were washed at 60oC in four 30 min steps: 1). 3 parts 50% formamide in 5 X SSC 
and 1 part 2 X SSC; 2). 1 part 50% formamide in 5 X SSC and 1 part 2 X SSC; 3). 1 part 
50% formamide in 5 X SSC and 3 parts 2 X SSC; 4).  2 X SSC. Slides were then washed at 
room temperature in 0.2 X SSC buffer, followed by two washes in maleic acid buffer 
(MAB; 0.1 M maleic acid, 0.15 M NaCl, pH 7.5) with 0.1% Tween 20 added. Sections 
were blocked in 0.5% Blocking Reagent (Roche Applied Science, Burgess Hill, UK) in 
MAB/0.1%Tween 20 for 1 h at room temperature in a moist chamber. After the blocking 
solution was drained from slides, 500 µl of anti-DIG alkaline phosphatase-Fab fragments 
(Roche Applied Science, Burgess Hill, UK) was added, diluted 1:5000 with 0.5% 
Blocking Reagent in MAB/0.1% Tween 20, and incubated overnight at 4oC in a moist 
chamber. Slides were washed two times for 10 min in PBS buffer, followed by 10 min in 
BCL buffer  (100 mM Tris, pH 9.5; 100 mM NaCl, 50 mM MgCl2, 0.1 % Tween 20) and 
then covered with a chromogen mixture consisting of 175 µg/ml 5-bromo-4-chloro-3-
indolyl phosphate (VWR, Lutterworth, UK), 337.5 µg/ml nitroblue tetrazolium (VWR, 
Lutterworth, UK) and lavamisole (Vector Labs. Inc., Burlingame, CA 94010, USA) in 
BCL buffer. When staining had developed (typically after 6-8 h), slides were washed 
two times in PBS and then post-fixed with 4% PFA in PBS for 30 min at room 
temperature. Finally, slides were dehydrated, cleared in xylene and prepared for 
microscopy by mounting coverslips over VectaMount (Vector Labs. Inc., Burlingame, 
CA 94010, USA). Sections were viewed under a Leica DMRA2 compound microscope 
(Leica, Nussloch, Germany) and digital images were captured using a Retiga 1300 
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monochrome 12 bit camera (QImaging; Burnaby, BC, Canada) and QCapture 1.1.6 
software (QImaging) running on a Macintosh G4 computer. Images were then processed 
to remove dust and assembled into figures using Photoshop 7.0 (Adobe Systems; San 
Jose, CA, USA) running on a MacBook Pro computer. Images were interpreted and 
labelled with reference to a mouse brain atlas (Paxinos and Franklin, 2001).
Production and characterisation of antibodies to NAPE-PLD
Antibodies to mouse NAPE-PLD were generated at QMUL using a synthetic 
peptide antigen (KHGESRYLNTDDRAFEET) comprising the C-terminal region of the 
protein (Okamoto et al., 2004), which was custom synthesised and purified by the 
Advanced Biotechnology Centre at Imperial College London. The antigen peptide 
(NAPE-PLDc) was coupled to thyroglobulin as a carrier protein via the N-terminal 
lysine residue using glutaraldehyde. Three female New Zealand white rabbits (2282, 
2283, 2284) were immunised with NAPE-PLDc-thyroglobulin conjugate (comprising 
~100 nmol NAPE-PLDc) emulsified with Freund’s complete adjuvant, followed by three 
monthly booster injections of conjugate (comprising ~ 50 nmol NAPE-PLDc) emulsified 
with Freund’s incomplete adjuvant. Samples of antiserum were collected one week after 
each booster injection.
Samples of antiserum from each of the bleeds from the three rabbits immunised 
were tested for the presence of anti-peptide antibodies using dot-blot assays. One µl of a 
1 mM solution of the NAPE-PLDc peptide (1 nmol) was pipetted onto a strip of 
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nitrocellulose membrane alongside negative controls comprising 1 µl of a 1 mM solution 
of an unrelated peptide (1 nmol) and a 1 µl sample of distilled water. Then after air-
drying and washing in PBS (pH 7.4) nitrocellulose membrane strips were blocked in 5% 
Marvel™ in PBS and incubated individually overnight at 4oC with of each of the antisera 
diluted 1:250 or 1:500 or 1:1000 in 1% Marvel™/0.05% Tween 20 in PBS (MPBST). After 
washing in MPBST, strips were incubated for two hours with alkaline phosphatase-
labelled goat anti-rabbit immunoglobulins (Vector Labs. Inc., Burlingame, CA 94010, 
USA) diluted 1:1000 in MPBST and then, after washing with 0.05% Tween 20 in PBS 
(PBST), bound antibodies were revealed using BCIP/NBT alkaline phosphatase 
substrate kit IV (Vector Labs. Inc., Burlingame, CA 94010, USA). 
Affinity purification of NAPE-PLD antibodies
Dot-blot analysis revealed the presence of anti-peptide antibodies in sera 
collected after the first, second and third boosts of the NAPE-PLDc-immunised rabbits. 
Samples of antiserum obtained from rabbits after the third and final boost (2282.3, 
2283.3, 2284.3) were subjected to affinity-purification using a column of NAPE-PLDc 
antigen peptide coupled to AminoLink® Gel (Pierce, Rockford, IL 61105, USA), prepared 
according to the manufacturer’s instructions. Bound antibodies were eluted with 15 ml 
100 mM glycine (G; pH 2.5) and then with 15 ml 100 mM triethylamine (T; pH 11.5), 
which were collected separately into tubes containing 1.5 ml 1M Tris-buffer (pH 8.0).
Western blotting
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Brains dissected from both wild-type (NAPE-PLD+/+) and knockout (NAPE-PLD-/-
) mice generated in the Cravatt lab (Leung et al., 2006) were snap frozen on dry-ice and 
sent to the Elphick lab for Western blot analysis. Following homogenisation on ice in a 
buffer comprising 2 mM Tris-EDTA, 5 mM MgCl2, 320 mM sucrose and protease 
inhibitors (Complete Mini; Roche Diagnostics Ltd, Lewes, E. Sussex, UK), particulate 
material was removed by centrifugation (5500 rpm) for 15 min at 4oC in an Eppendorf 
5804R centrifuge. Samples of brain homogenate supernatants (50 or 75 µg protein per 
lane) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) using a 10% polyacrylamide Tris-glycine gel under reducing conditions, 
with material from NAPE-PLD+/+ and NAPE-PLD-/- mice in alternating lanes. Gels were 
transblotted to nitrocellulose membrane, which was then cut into strips corresponding 
to two adjacent lanes. The nitrocellulose membrane strips were incubated with 5% 
Marvel in PBS for 1 h at room temperature and then incubated individually overnight at 
4oC with antisera (1:500) or with one of the six fractions of affinity-purified NAPE-PLD 
antibody fractions collected (2282.3G, 2282.3T, 2283.3G, 2283.3T, 2284.3G and 2284.3T) 
diluted 1:5 or 1:10 or 1:15 in MPBST. After washing in MPBST, strips were incubated for 
two hours with alkaline phosphatase-labelled goat anti-rabbit immunoglobulins (Vector 
Labs. Inc., Burlingame, CA 94010, USA) diluted 1:1000 in MPBST and then, after 
washing with 0.05% Tween 20 in PBS (PBST), bound antibodies were revealed using 
BCIP/NBT alkaline phosphatase substrate kit IV (Vector Labs. Inc., Burlingame, CA 
94010, USA). 
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Immunocytochemistry
Preliminary immunocytochemical analysis of NAPE-PLD expression was 
performed using brains from mice of the BALB/c strain to establish methodology prior 
to analysis of brains from male NAPE-PLD-knockout mice (NAPE-PLD-/-) and male 
wild-type littermates (NAPE-PLD+/+). Two different methods for preparation of brain 
sections were tested: 1. Sectioning of paraffin-wax embedded brains fixed with 4% PFA 
in PBS and post-fixed in Bouin’s fixative, as described previously (Egertová et al., 2003)
or 2. Sectioning of frozen brains fixed with 4% PFA in PBS. The latter method was found 
to be preferable for immunocytochemical visualisation of NAPE-PLD expression using 
the antibodies developed in this study and therefore this method is described in detail 
below.
Mice were asphyxiated with CO2 and perfused through the heart with 25 ml of 
4% PFA in PBS (pH 7.4) and then brains were removed and transferred to fresh fixative 
for 1 - 4 days. Then after washing in PBS (2 x 1 hr), brains were cryoprotected overnight 
with 20% sucrose in PBS. Serial sets of coronal sections (20 µm) of brains were prepared 
using a Leica freezing microtome (CM3050S) and collected as free-floating sections in 
PBS containing 0.05% sodium azide. Sections were washed in PBS and incubated with 
~3% hydrogen peroxide in PBS for 30 min at room temperature to quench endogenous 
peroxidase activity. After washing in PBST, sections were blocked with 5% normal goat 
serum (NGS) in PBS with 0.2% Triton-X100 (PBSTx) for 2 h at room temperature. 
Page 14 of 46
John Wiley & Sons
Journal of Comparative Neurology
For Peer Review
15
Sections were then incubated overnight at 4oC with affinity-purified antibodies to mouse 
NAPE-PLD (2282.3T) diluted 1:7 - 1:10 in PBSTx with 5% NGS and 0.05% sodium azide 
added. After washing in PBSTx, slides were incubated for 4 h at room temperature with 
horseradish-peroxidase conjugated goat anti-rabbit immunoglobulins (Jackson 
ImmunoResearch). Then after washing in PBS, bound antibodies were revealed using 
diaminobenzidine (with nickel) as a substrate (Vector Labs. Inc., Burlingame, CA 94010, 
USA).
Finally, free-floating sections were collected on polysine slides (VWR), 
dehydrated, cleared in xylene and prepared for microscopy by mounting coverslips 
over DPX. Images of stained sections were then captured as described above for mRNA 
in situ hybridisation.
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RESULTS
Localisation of NAPE-PLD mRNA in mouse brain
The most striking feature of NAPE-PLD expression in mouse brain revealed by 
mRNA in situ hybridisation with DIG-labelled antisense RNA probes was in the 
hippocampal formation, where intense staining was evident in the granule cell layer of 
the dentate gyrus (Fig. 1A). No staining was observed in the dentate gyrus in control 
experiments where a DIG-labelled sense RNA probe was tested on sections of wild-type 
mouse brains (Fig. 1B) or where the DIG-labelled antisense RNA probe was tested on 
brains from NAPE-PLD knockout mic  (Fig. 1C), demonstrating the specificity of our 
methods for visualising NAPE-PLD mRNA. 
NAPE-PLD expression was also detected in other brain regions, but staining was 
less intense than in the granule cell layer of the dentate gyrus (Fig. 2A,B). For example, 
in Fig. 2A compare the staining in the granule cell layer of the dentate gyrus (DG) with 
staining in the pyramidal cell layer of the hippocampus (Hi) and staining of cells in 
medial geniculate thalamic nucleus (MG). Expression of NAPE-PLD in other brain 
regions is described below and illustrated in Fig. 2. 
 In the hippocampus, staining was present in pyramidal cells throughout all three 
fields (CA1-CA3), as illustrated in Fig. 2C (CA1; low magnification) and Fig. 2D (CA3; 
high magnification). In Fig. 2C, note again the higher intensity of staining in the granule 
cell layer of the dentate gyrus compared to staining in the CA1 pyramidal cell layer.
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NAPE-PLD mRNA expression was detected in several regions of the olfactory 
system. In the olfactory bulb, staining was present in granule cells (Fig. 2E) and 
periglomerular cells (not shown). In olfactory cortex, staining was present in neuronal 
cell body layers in the olfactory tubercle (Fig. 2F) and the piriform cortex (Fig. 2G). In 
the amygdaloid complex, staining was associated with cells in the cortical and medial 
amygdaloid nuclei (Fig. 2H), whilst the basal (Fig. 2H) and lateral nuclei (not shown) 
had less staining.
Staining was present in several thalamic nuclei, but at quite low intensity; for 
examples, see Fig. 1A showing lateral posterior nuclei and Fig. 2A showing the medial 
geniculate nucleus. In the hypothalamus, staining was evident in cells of the 
ventromedial nucleus (Fig. 2I). In the neocortex staining was widespread but typically at 
a low intensity; for example, see Fig. 2J showing an area of visual cortex. In some 
neocortical areas, however, more intense staining was evident in superficial neuronal 
cell body layers; for example see Fig. 2K showing retrosplenial cortex. In the cerebellar 
cortex, staining was present in the granule cell layer and Purkinje cell layer, but not in 
the molecular layer or white matter (Fig. 2L).
Collectively, the results obtained from mRNA in situ hybridisation experiments 
indicate that NAPE-PLD is expressed by neurons in several brain regions, but with 
variation between neuronal types in the levels of NAPE-PLD expression. However, for 
these observations to be interpreted from a functional perspective, immunocytochemical 
analysis of the distribution of NAPE-PLD protein in brain is necessary. 
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Western blot analysis of brain homogenates from NAPE-PLD+/+ and NAPE-PLD-/- mice 
with antisera and affinity-purified antibodies to the C-terminal region of mouse 
NAPE-PLD
Western blot analysis of brain homogenates from NAPE-PLD+/+ mice using 
antisera (2282.3, 2283.3, 2284.3) revealed several immunoreactive bands, ranging in 
molecular mass from ~25 kDa to ~150 kDa (Fig. 3A,B,C, respectively). The most 
intensely stained band revealed by the 2282.3 antiserum (Fig. 3A) and the 2284.3 
antiserum (Fig. 3C) was located between the 37 kDa and 50 kDa markers, which is 
consistent with the expected molecular mass for NAPE-PLD (~ 46 kDa). However, this 
band was also detected in brain homogenates from NAPE-PLD-/- mice, as indeed were 
other immunoreactive bands in brain homogenates from NAPE-PLD+/+ mice (Fig. 3A,C). 
Thus, the strongly immunoreactive band located between the 37 kDa and 50 kDa 
markers is not in fact NAPE-PLD but is another protein with a molecular mass very 
similar to NAPE-PLD that is recognised by antibodies present in the 2282.3 and 2284.3 
antisera. Hence, it was necessary to affinity-purify antibodies to the NAPE-PLD C-
terminal peptide antigen. 
Immunoglobulins eluted with glycine (G) and  triethylamine (T) were collected 
separately and then tested in Western blots of brain homogenates from NAPE-PLD+/+
and NAPE-PLD-/- mice (Fig. 3D,E,F). 2282.3(G) labelled a band in NAPE-PLD+/+ brain 
homogenates with a molecular mass of ~46 kDa, which was not detected in NAPE-PLD-
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/- brain homogenates (Fig. 3D). However, with 2282.3(G) two strongly immunostained 
bands located between the 25 kDa and 37 kDa markers were also detected in both 
NAPE-PLD+/+ and NAPE-PLD-/- brain homogenates. 2282.3(T) revealed a single band in 
NAPE-PLD+/+ brain homogenates with the expected molecular mass for NAPE-PLD (~ 
46 kDa), which was absent in NAPE-PLD-/- mouse brain homogenates (Fig. 3D). 
Therefore, the 2282.3(T) fraction appeared to contain antibodies that selectively 
recognise NAPE-PLD and which we therefore used for immunocytochemical analysis of 
NAPE-PLD expression in mouse brain (see below). In contrast to 2282.3(T), affinity-
purified antibodies derived from the 2283.3 and 2284.3 antisera exhibited cross-
reactivity with multiple protein bands that were present in both NAPE-PLD+/+ and 
NAPE-PLD-/- brain homogenates (Fig. 3E,F) and therefore these antibodies were not 
used for subsequent immunocytochemical studies.
Immunocytochemical localisation of NAPE-PLD in mouse brain
Immunocytochemical analysis of brain sections from NAPE-PLD+/+ mice using 
the 2282.3(T) antibodies revealed a widespread pattern of immunostaining. For 
example, in Fig. 4A immunoreactivity can be seen in the dentate gyrus (DG), 
hippocampus (Hi) and the ventral (VTN) and mediodorsal (MD) thalamic nuclei. To 
assess the specificity of the immunostaining observed in brains from NAPE-PLD+/+ mice, 
the 2282.3(T) antibodies were also tested on sections of brains from NAPE-PLD-/- mice. 
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The majority of immunostaining observed in brains from NAPE-PLD+/+ mice, which is 
described in more detail below, was not seen in brains from NAPE-PLD-/- mice and 
therefore can be attributed specifically to expression of NAPE-PLD. For example, Fig. 4B 
shows a coronal brain section from a NAPE-PLD-/- mouse that is in an intermediate 
position with respect to the wild-type brain sections shown in Fig. 4A and Fig. 4C; note 
that the staining of the dentate gyrus, hippocampus and thalamus that can be seen in 
Fig. 4A is absent in Fig. 4B, demonstrating that this staining can be specifically 
attributed to NAPE-PLD expression. However, there are structures that are stained in 
both Fig. 4A and 4B, including the ependyma lining the lateral ventricles (see arrow 
heads) and the cell bodies and processes of hypothalamic magnocellular neurosecretory 
cells (see asterisks). This staining is th refore is not attributable to NAPE-PLD 
expression and must be due to cross-reaction of the NAPE-PLD antibodies with other 
proteins. Likewise, staining of ventricular ependyma and choroid plexus that can be 
seen in 4C-F is also not attributable to expression of NAPE-PLD.
The images of NAPE-PLD immunoreactivity (ir) in wild-type mouse brain 
sections shown in Fig. 4 provide an overview of the most prominent features. In 
addition to staining associated with the dentate gyrus, hippocampus and thalamus, 
which was highlighted above, immunoreactivity is also evident in the neocortex, 
olfactory (piriform) cortex, hypothalamus and amygdaloid complex. More detailed 
interpretation of the immunostaining, however, requires images of higher magnification 
than those shown in Fig. 4. Therefore, selected higher magnification images of several 
regions of the brain are shown in Fig. 5 and described below. In all brain regions where 
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immunostaining was detected, the staining was not evident in neuronal somata but 
appeared to be localised in stained fibres surrounding unstained cell bodies and 
dendrites.    
The most striking feature of NAPE-PLD expression in the mouse brain was 
intense NAPE-PLD-ir present in the polymorphic layer of the dentate gyrus (Fig. 5A), 
where the pattern of staining was consistent with localisation of NAPE-PLD in mossy 
fibres, the axons of dentate gyrus granule cells (Longo et al., 2003). Accordingly, analysis 
of immunostained sections at high magnification revealed that NAPE-PLD-ir was 
localised in mossy fibre varicosities surrounding unstained cells in the polymorphic 
layer (Fig. 5B). Immunolabelled mossy fibres were also evident in the stratum lucidum 
of the CA3 region of the hippocampus (Fig. 5C). Weaker immunostaining was evident 
in the stratum radiatum and stratum oriens of the hippocampal CA1-CA3 fields (Fig. 
5A,D), surrounding unstained somata and dendrites of pyramidal cells (Fig. 5E). In the 
neocortex, immunostaining was present in superficial layers, but layer VI was only very 
weakly stained.
In addition to the polymorphic layer of the dentate gyrus, a second region of the 
brain with very intense immunostaining was the accessory olfactory bulb. Here NAPE-
PLD-ir was localised in glomeruli and in axons that project into the accessory olfactory 
bulb from the vomeronasal nerve (Fig. 5G,H). Immunostaining was also present in the 
granule cell layer and glomerular layer of the main olfactory bulb, but this staining was 
less intense than staining in the vomeronasal nerve and the accessory olfactory bulb 
(Fig. 5H).
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Other regions of the forebrain where NAPE-PLD-ir was present included the
caudate putamen and the lateral nucleus of the septum (Fig. 5I,J). The majority of 
thalamic nuclei were immunostained, as can be seen in the low magnification images of 
Fig. 4. A higher magnification image of immunostaining in the medial and laterial 
geniculate nuclei is shown in Fig. 5K.  Compared to the forebrain, relatively little 
staining was evident in the midbrain and hindbrain. For example, in the cerebellar 
cortex very weak immunostaining was present in the molecular layer (Fig. 5L) at an 
intensity close to the threshold for detection.     
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DISCUSSION
Here we describe the distribution of NAPE-PLD expression in the mouse brain, 
utilising mRNA in situ hybridisation methods and novel antibodies to a NAPE-PLD C-
terminal peptide antigen. Importantly, we have employed use of NAPE-PLD knockout 
mice (NAPE-PLD-/-) for unequivocal evaluation of the specificity of NAPE-PLD 
antibodies and the immunostaining observed in brains from wild-type mice (NAPE-
PLD+/+). NAPE-PLD mRNA was detected in the somata of identified neuronal 
populations in several regions of the brain, including granule cells in the dentate gyrus, 
olfactory bulb and cerebellar cortex and pyramidal cells in the hippocampus and cortex. 
NAPE-PLD immunoreactivity was not, however, dectected in the somata of these or any 
other neuronal populations and the patterns of immunostaining revealed by antibodies 
to NAPE-PLD indicate that this enzyme is targeted to axons. Although we cannot 
exclude the possibility that NAPE-PLD is also expressed by glial cells in the brain, the 
immunostaining obtained provided no evidence of non-neuronal expression.
Importantly, the overall regional distribution of NAPE-PLD mRNA in mouse 
brain correlated with the distribution of NAPE-PLD protein. For example, both NAPE-
PLD mRNA and protein are very abundant in the hippocampal formation but are 
present at relatively low levels in the cerebellum. Previously, the relative abundance of 
NAPE-PLD in different regions of the rat brain has been investigated by measurement 
of NAPE-PLD enzyme activity, Western blotting and real time PCR (Morishita et al., 
2005). NAPE-PLD was detected in all rat brain regions analysed but it was most 
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abundant in the thalamus. Our data also indicate that NAPE-PLD is widely expressed in 
thalamus, but based on the intensity of immunostaining it appears that in mouse brain 
NAPE-PLD is more abundant in the hippocampal formation. There may therefore be 
species differences in the relative abundance of NAPE-PLD in brain regions. 
Within regions of the mouse brain mRNA in situ hybridisation and 
immunocytochemistry typically yielded complementary patterns of staining, which can 
be attributed to the targeting of NAPE-PLD protein to the axons of neuronal somata that 
express the NAPE-PLD gene. There was also correspondence in the relative intensity of 
staining revealed by mRNA and protein labelling methods in different neuronal 
populations. Thus, neurons strongly labelled for NAPE-PLD mRNA had intense NAPE-
PLD-ir in their axons (e.g. dentate gyrus granule cells). Conversely, neuronal 
populations with a weaker mRNA signal (e.g. olfactory bulb granule cells) had 
correspondingly lower levels of axonal NAPE-PLD-ir.    
The brain region with the most striking pattern of NAPE-PLD expression was the 
dentate gyrus, where a strong NAPE-PLD mRNA signal was detected in granule cells 
and intense NAPE-PLD immunoreactivity was present in the varicose axons of these 
cells (mossy fibres). This high level of NAPE-PLD expression in granule cells is of 
particular interest from a functional perspective because the dentate gyrus is part of the 
hippocampal formation, which has a fundamental role in some forms of learning and 
memory as well as having high seizure susceptibility. In hippocampal circuitry, the 
dendrites of granule cells in the molecular layer of the dentate gyrus receive excitatory 
input from the entorhinal cortex via the perforant pathway. Then axons of granule cells 
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(mossy fibres) form en passant synapses with neurons such as mossy cells in the 
polymorphic layer of the dentate gyrus before projecting to the CA3 region of the 
hippocampus, where they synapse onto the proximal dendrites of pyramidal cells. The 
presence of intense NAPE-PLD immunoreactivity in the axons of mossy fibres both in 
the polymorphic layer of the dentate gyrus and in the stratum lucidum of the CA3 field 
of the hippocampus suggests, therefore, that NAPE-PLD may be involved in regulation 
of hippocampal synaptic transmission. However, there is at present no direct evidence 
of such a role and testing this hypothesis may require the development of novel 
selective inhibitors of NAPE-PLD and/or comparison of hippocampal synaptic 
transmission in NAPE-PLD+/+ and NAPE-PLD-/- mice. 
The discovery that NAPE-PLD appears to be principally involved in biosynthesis 
of saturated, long-chain (e.g. C20:0 and C22:0) NAEs in the brain (Leung et al., 2006)
focuses attention on the physiological roles of these lipids in the brain. Based on the 
observations reported here, it would be of particular interest to analyse the effects of 
these molecules on synaptic transmission between mossy fibres and mossy cells or CA3 
pyramidal cells. We speculate that NAEs generated by NAPE-PLD in the pre-synaptic 
axon termimals of mossy fibres may function as anterograde synaptic signalling 
molecules, acting post-synaptically and influencing the activity of mossy cells and CA3 
pyramidal cells. Furthermore, although whole-brain levels of anandamide are unaltered 
in NAPE-PLD-/- mice, it is still possible that NAPE-PLD contributes to 
anandamide/endocannabinoid signalling, particularly in brain regions where its 
expression is high (e.g. hippocampal formation).  
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In animal models of temporal lobe epilepsy sprouting of mossy fibres is 
observed, with the formation of new synapses between mossy fibre terminals and 
dendrites of granule cells and inhibitory interneurons occurring in the inner third of the 
molecular layer of the dentate gyrus (Longo et al., 2003). NAPE-PLD-ir is more intense 
in the inner third of the molecular layer (IML) than in more superficial layers (Fig. 5D), 
which may reflect the presence of NAPE-PLD in mossy fibre terminals in the IML. 
Therefore, an increase in the intensity of NAPE-PLD-ir in the IML may accompany 
sprouting of mossy fibres in temporal lobe epilepsy. Moreover, the abundance of NAPE-
PLD in mossy fibres provides a rationale for investigation of a potential role for NAPE-
PLD and the NAEs that it generates in regulation of hippocampal seizure activity.
A second region of the brain with particularly intense NAPE-PLD-ir was the 
accessory olfactory bulb, where immunostaining was localised in axons projecting from 
the vomeronasal nerve. These axons originate from the vomeronasal organ, which 
contains pheromone-sensitive receptor neurons (Brennan, 2001). The presence of NAPE-
PLD in vomeronasal axons suggests, therefore, that this enzyme and the NAEs it 
generates may participate in synaptic mechanisms associated with neural processing of 
pheromone-stimulated electrical activity in the accessory olfactory bulb. Interestingly, 
NAPE-PLD-ir is also present in the glomerular layer of the main olfactory bulb and 
associated with axons derived from olfactory nerve, but this immunostaining is less 
intense than in the vomeronasal axons associated with the accessory olfactory bulb.
The expression of NAPE-PLD by other neuronal populations in the forebrain is 
not as striking as in dentate gyrus mossy fibres or vomeronasal axons but nevertheless 
Page 26 of 46
John Wiley & Sons
Journal of Comparative Neurology
For Peer Review
27
important to consider. However, detailed discussion of NAPE-PLD expression in all 
regions of the brain where it is detected would be excessive and therefore we will focus 
on a few selected brain regions.
In the hippocampus, NAPE-PLD mRNA is present in pyramidal cells of the CA1-
CA3 fields and the pattern of NAPE-PLD immunoreactivity in the hippocampus, with 
immunostaining surrounding but not localised within pyramidal cell somata or 
dendrites, is consistent with targeting of the NAPE-PLD protein to the axons of 
hippocampal pyramidal cells. Thus, NAEs generated by NAPE-PLD may be involved in 
regulation of excitatory synaptic transmission throughout the hippocampal formation.
In the cortex, NAPE-PLD mRNA expression was clearly evident in pyramidal 
cells of the olfactory cortex but in the neocortex the intensity of staining for NAPE-PLD 
mRNA expression was typically rather low. Nevertheless, analysis of NAPE-PLD 
immunoreactivity in the cortex revealed a pattern of staining consistent with axonal 
targeting of NAPE-PLD in cortical pyramidal cells. Interestingly, the intensity of NAPE-
PLD immunostaining was higher in superficial layers of the neocortex than in layer VI, 
which may reflect axonal targeting of NAPE-PLD in superficial pyramidal cells that 
project within the cortex.
In the cerebellar cortex NAPE-PLD mRNA expression was detected in the 
granule cell layer and weak NAPE-PLD-ir was detected in the molecular layer. These 
data indicate that the NAPE-PLD gene is expressed by cerebellar granule cells and, 
consistent with evidence from other brain regions, NAPE-PLD protein is targeted to the 
axons of these neurons (parallel fibres) in the molecular layer. Furthermore, if NAEs 
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generated by NAPE-PLD act as anterograde synaptic signalling molecules, as suggested 
above, then NAEs generated pre-synaptically in parallel fibres may influence the 
activity of post-synaptic Purkinje cells.
NAEs generated by NAPE-PLD in the brain are potential substrates for the 
degradative enzyme fatty acid amide hydrolase (FAAH) (Cravatt et al., 2001; Cravatt et 
al., 1996; Patricelli and Cravatt, 2001). Thus, the physiological half-life of NAEs 
generated by NAPE-PLD in the brain may be influenced by the proximity and relative 
abundance of FAAH. It is of interest, therefore, to compare the distribution of NAPE-
PLD and FAAH in the mouse brain. The distribution of FAAH expression in the rat and 
mouse brain has been analysed previously using immunocytochemical techniques 
(Egertová et al., 2003; Egertová et al., 1998; Egertová et al., 2004; Tsou et al., 1998). Like 
NAPE-PLD, FAAH is widely expressed but with regional and cellular variation in its 
relative abundance. FAAH is expressed by many neuronal populations and is also 
expressed in ventricular ependymal cells and oligodendrocytes. Interestingly, in 
neurons that express the FAAH gene the FAAH protein is typically targeted to the 
somatodendritic neuronal compartment (Egertová et al., 2003; Gulyas et al., 2004). Thus, 
it appears that NAPE-PLD and FAAH are targeted to different sub-cellular 
compartments in neurons, giving rise to complementary distribution patterns. For 
example, in the hippocampus FAAH is expressed by pyramidal cells and targeted to 
their somatodendritic compartment (Egertová et al., 2003; Gulyas et al., 2004), whilst the 
data presented in this paper indicate that NAPE-PLD is targeted to the axons of 
pyramidal cells. Likewise, both FAAH and NAPE-PLD are widely expressed in thalamic 
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nuclei, but FAAH-ir is present in neuronal somata (Egertová et al., 2003) and NAPE-
PLD-ir surrounds unstained neuronal somata. This suggests that if NAEs generated by 
NAPE-PLD in the brain are utilised as anterograde synaptic signalling molecules, then 
the presence of FAAH in neuronal somata and dendrites may facilitate rapid post-
synaptic inactivation of these molecules.
In conclusion, the data presented in this paper provide the first insight into the 
neuroanatomy of NAPE-PLD expression in the brain and a new perspective on the 
neural functions of this enzyme and NAEs that it generates. Our finding that NAPE-
PLD is targeted to the axons and axon terminals of identified neurons provides a basis 
for investigation of a potential role for NAEs as mediators of anterograde signalling at 
synapses.   
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FIGURE LEGENDS
Fig. 1. Validation of the specificity of mRNA in situ hybridisation methods used to 
visualise NAPE-PLD expression in mouse brain. A: DIG-labelled antisense RNA probes 
reveal intense staining in the granule cell layer of the dentate gyrus (GrDG) in wild-type 
mouse brain. Weakly stained cells can also be seen in the lateral posterior thalamic 
nucleus (LPTN). B: No staining is observed when wild-type mouse brain sections are 
incubated with DIG-labelled sense RNA probes, indicating that the staining observed in 
A is specific and attributable to NAPE-PLD expression. C: No staining is observed when 
brain sections from NAPE-PLD knockout mice are incubated with DIG-labelled 
antisense RNA probes, demonstrating that the staining observed in A is specific and 
attributable to NAPE-PLD expression. Abbreviations: GrDG, granule cell layer of dentate 
gyrus; LPTN, lateral posterior thalamic nucleus; Mol, molecular layer of the dentate 
gyrus; PoDG, polymorphic layer of the dentate gyrus. Scale bar = 200 µm.
Fig. 2. NAPE-PLD expression in mouse brain as revealed by mRNA in situ hybridisation 
with DIG-labelled antisense RNA probes. A: The intense staining of the granule cell 
layer of the dentate gyrus (DG) can be seen here in contrast to less intense staining in the 
CA3 pyramidal cell layer of the hippocampus (Hi) and weakly stained cells in the 
medial geniculate nucleus (MG). B: High magnification image of the dentate gyrus 
showing stained granule cells (GrDG). C: The intense staining in the granule cell layer of 
the dentate gyrus (GrDG) is contrasted here with less intense staining in the CA1 
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pyramidal cell layer (Py) of the hippocampus. D: High magnification image of the CA3 
region of the hippocampus showing stained pyramidal cells (Py). E: In the olfactory 
bulb stained granule cells can be seen here in the granule cell layer (GrO) and in the 
mitral cell layer (Mi). F: Stained cells in the olfactory tubercle. G: Stained cells in the 
piriform cortex. H: Stained cells in the piriform cortex (Pir) can be seen here in contrast 
to less intense staining in the cortical (CA) and medial (MA) amygdaloid nuclei and 
very weak staining in the basomedial amygdaloid nucleus (BMA). I: Stained cells in the 
ventromedial hypothalamic nucleus (VM). J: Weakly stained cells in visual neocortex; 
the asterisk labels layer I of the cortex. K: Retrosplenial neocortex, with staining 
strongest in the superficial cellular layers; the asterisk labels layer I of the cortex. L:
Cerebellar cortex, with staining evident in both the granule cell layer (GCL) and 
Purkinje cell layer (PCL) but not in the molecular layer (ML) or white matter (WM). 
Abbreviations: BMA, basomedial amygdaloid nuclei; CA, cortical amygdaloid nuclei; DG, 
dentate gyrus; EPl, external plexiform layer of the olfactory bulb; GrDG, granule cell 
layer of the dentate gyrus; GrO, granule cell layer of the olfactory bulb; GCL, granule 
cell layer of the cerebellar cortex; Hi, hippocampus; LMol, lacunosum moleculare layer; 
IPl, internal plexiform layer of the olfactory bulb; Mi, mitral cell layer of the olfactory 
bulb; MA, medial amygdaloid nuclei; MG, medial geniculate thalamic nucleus; ML, 
molecular layer of the cerebellar cortex; Or, stratum oriens of the hippocampus; Ov, 
olfactory ventricle; PoDG, polymorphic layer of the dentate gyrus; Pir, piriform cortex; 
PCL, Purkinje cell layer; Py, pyramidal cell layer of the hippocampus; Rad, stratum 
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radiatum of the hippocampus; Tu, olfactory tubercle; VP, ventral pallidum; WM, white 
matter. Scale bar = 50 µm in B, D, L; 100 µm in C, E, F, G, I, J, K; 200 µm in A, H. 
Fig. 3. Characterisation of antisera (A, B, C) and affinity-purified antibodies (D, E, F) to 
mouse NAPE-PLD by Western blot analysis of brain homogenates from NAPE-PLD+/+
and NAPE-PLD-/- mice. NAPE-PLD antisera [A: 2282.3(AS), B: 2283.3(AS), C: 
2284.3(AS)] label bands in wild-type (+/+) brains with a wide range of molecular 
masses, including an intensely stained band between 37 kDa and 50 kDa markers with a 
molecular mass similar to that expected for mouse NAPE-PLD (~46 kDa). However, all 
the stained bands evident in wild-type brains, including the intensely stained band 
between 37 kDa and 50 kDa markers, are also detected in brains from knockout animals 
(-/-) and therefore are not NAPE-PLD, demonstrating the necessity for affinity-
purification of antibodies to the NAPE-PLD C-terminal peptide antigen. D: Affinity-
purifed antibodies derived from the 2282.3 antiserum and eluted with glycine (G) or 
triethylamine (T) label a ~ 46 kDa band in wild-type (+/+) brain homogenates that it is 
not present in knockout (-/-) brain homogenates and which therefore must be NAPE-
PLD (see arrow). The 2282.3(G) antibodies also label two bands between the 25 kDa and 
37 kDa markers that are present in both wild-type and knockout brain homogenates. 
However, 2282.3(T) antibodies only stain the ~ 46 kDa band corresponding to NAPE-
PLD and therefore these antibodies were selected for immunocytochemical analysis of 
NAPE-PLD expression in mouse brain. E, F: Affinity-purifed antibodies derived from 
the 2283.3 and 2284.3 antisera also label a ~46 kDa band corresponding to NAPE-PLD 
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(see arrows). However, these antibodies also cross-react with other proteins and 
therefore were not used for immunocytochemical analysis of NAPE-PLD expression in 
mouse brain.
Fig. 4. Immunoreactivity in coronal sections of mouse forebrain (A,C,D,E,F) attributable 
to NAPE-PLD expression by comparative immunocytochemical analysis NAPE-PLD-/- 
mice (B). A:  Immunostaining in anterior regions of the dentate gyrus (DG), 
hippocampus (Hi) and thalamus (MD, VTN). B: Immunostaining is almost completely 
absent in this coronal section of NAPE-PLD knockout mouse brain positioned 
intermediate with respect to the sections of wild-type brain shown in A and C. The only 
staining present is in ventricular ependyma (arrow head) and in hypothalamic 
magnocellular neurons (*) and, with the exception of these features, all of the staining in 
wild-type brain (A, C, D, E, F) is specifically attributable to NAPE-PLD expression. C, D, 
E, F: Here, in addition to immunostaining in the hippocampal formation (DG, Hi) and 
thalamus (Gus, LG, MD, MG, Po, VP), NAPE-PLD immunoreactivity is also present in 
the neocortex (NC), piriform cortex (Pir), amygdaloid complex (AmC) and 
hypothalamus (Hy). Abbreviations: AmC, amygdaloid complex; CPu, caudate putamen; 
DG, dentate gyrus; Gus, gustatory thalamic nucleus; Hi, hippocampus; ic, internal 
capsule; LG, lateral geniculate thalamic nucleus; MD, mediodorsal thalamic nucleus; 
MG, medial geniculate thalamic nucleus; NC, neocortex; Pir, piriform cortex; Po, 
posterior thalamic nucleus; VP, ventroposterior thalamic nucleus; VTN, ventral thalamic 
nuclei. Scale bar = 500 µm.   
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Fig. 5. Localisation of NAPE-PLD immunoreactivity in mouse brain regions. A: In the 
hippocampal formation intense immunostaining is present in the polymorphic layer of 
the dentate gyrus (PoDG). Strong staining is also present in the stratum lucidum (see 
white asterisk) in the CA3 field of the hippocampus. Weaker staining is evident in the 
molecular layer of the dentate gyrus (Mol), the stratum oriens (Or) and the stratum 
radiatum (Rad) in the CA1 - CA3 fields of the hippocampus and the laterodorsal 
thalamic nucleus (LDTN). B: High magnification image showing immunostained mossy 
fibre axons with varicosities surrounding unstained cells (see asterisks) in the 
polymorphic layer of the dentate gyrus. C: Intensely immunostained mossy fibre axons 
can be seen here in the stratum lucidum (SLu) in the CA3 field of the hippocampus. Less 
intense staining can be seen in the stratum radiatum (Rad) and stratum oriens (Or). Note 
the absence of immunostaining in cell bodies of the pyramidal cell layer (Py). D: Here 
the intensity of immunostaining in hippocampal and neocortical (NC) layers can be 
compared; the external capsule (ec) marks the boundary between the neocortex and 
hippocampus. Note that in the molecular layer of the dentate gyrus (Mol) the intensity 
of staining in the inner zone (arrow head) is slightly stronger than in the outer zone of 
this layer. E: Immunostaining in the CA1 field of the hippocampus; note that in the 
stratum radiatum (Rad) immunostaining surrounds the unstained primary dendrites of 
pyramidal cells. F: Immunstaining in neocortex (auditory); note that staining is more 
intense in superficial layers (Sup) of the cortex than in layer VI. G: Intense 
immunostaining is present in the vomeronasal nerve (VN) and its axonal projections 
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into the glomerular layer of the accessory olfactory bulb (AOB); staining in lateral orbital 
cortex can also be seen in this image. H: Immunostaining is present in the olfactory 
nerve (ON) and the glomerular layer (Gl) of the main olfactory bulb but is less intense 
than in the vomeronasal nerve (VN); weak staining is also evident here in the granule 
cell layer of the olfactory bulb. I: Low magnification view of anterior forebrain showing 
immunostaining in cingulate (Cg) and motor (M1, M2) cortex, septum (S) and caudate 
putamen (CPu). J: In the septum immunostaining is present in the lateral septal nuclei 
(LS) but not in the medial septal nucleus (MS). K: Immunostaining in posterior thalamic 
nuclei (LG, MG, LP); note the difference in the intensity of thalamic staining and 
immunostaining in the adjacent dentate gyrus (DG). L: In the cerebellar cortex, very 
weak immunostaining is evident in th  molecular layer (ML). Abbreviations: AOB, 
accessory olfactory bulb; cc, corpus callosum; cg, cingulated cortex; CPu, caudate 
putamen; DG, dentate gyrus; ec, external capsule; EPl, external plexiform layer of the 
olfactory bulb; GCL, granule cell layer of the cerebellar cortex; GrDG, granule cell layer 
of the dentate gyrus; Gl, glomerular layer of the olfactory bulb; GrO, granule cell layer 
of the olfactory bulb; IPl, internal plexiform layer of the olfactory bulb; LDTN, 
laterodorsal thalamic nucleus; LG, lateral geniculate thalamic nucleus; LMol, lacunosum 
moleculare layer; LO, lateral orbital cortex; LP, lateroposterior thalamic nucleus; LS, 
lateral septal nucleus; M1, primary motor cortex; M2, secondary motor cortex; Mi, mitral 
cell layer of the olfactory bulb; MA, medial amygdaloid nuclei; MG, medial geniculate 
thalamic nucleus; ML, molecular layer of the cerebellar cortex; MOB, main olfactory 
bulb; Mol, molecular layer of the dentate gyrus; MS, medial septal nucleus; ON, 
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olfactory nerve; Or, stratum oriens of the hippocampus; NC, neocortex; PoDG, 
polymorphic layer of the dentate gyrus; Pir, piriform cortex; PCL, Purkinje cell layer; Py, 
pyramidal cell layer of the hippocampus; Rad, stratum radiatum of the hippocampus; S, 
septum; SLu, stratum lucidum of the hippocampus;. Scale bars = 15 µm in B; 50 µm in C, 
E, F; 100 µm in G, H; 200 µm in A, D, J, K, L; 500 µm in I.
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Fig. 1. Validation of the specificity of mRNA in situ hybridisation methods used to 
visualise NAPE-PLD expression in mouse brain. A: DIG-labelled antisense RNA probes 
reveal intense staining in the granule cell layer of the dentate gyrus (GrDG) in wild-type 
mouse brain. Weakly stained cells can also be seen in the lateral posterior thalamic 
nucleus (LPTN). B: No staining is observed when wild-type mouse brain sections are 
incubated with DIG-labelled sense RNA probes, indicating that the staining observed in A
is specific and attributable to NAPE-PLD expression. C: No staining is observed when 
brain sections from NAPE-PLD knockout mice are incubated with DIG-labelled antisense 
RNA probes, demonstrating that the staining observed in A is specific and attributable to 
NAPE-PLD expression. Abbreviations: GrDG, granule cell layer of dentate gyrus; LPTN, 
lateral posterior thalamic nucleus; Mol, molecular layer of the dentate gyrus; PoDG, 
polymorphic layer of the dentate gyrus. Scale bar = 200 5m. 
108x268mm (300 x 300 DPI)  
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Fig. 2. NAPE-PLD expression in mouse brain as revealed by mRNA in situ hybridisation 
with DIG-labelled antisense RNA probes. A: The intense staining of the granule cell layer 
of the dentate gyrus (DG) can be seen here in contrast to less intense staining in the CA3 
pyramidal cell layer of the hippocampus (Hi) and weakly stained cells in the medial 
geniculate nucleus (MG). B: High magnification image of the dentate gyrus showing 
stained granule cells (GrDG). C: The intense staining in the granule cell layer of the 
dentate gyrus (GrDG) is contrasted here with less intense staining in the CA1 pyramidal 
cell layer (Py) of the hippocampus. D: High magnification image of the CA3 region of the 
hippocampus showing stained pyramidal cells (Py). E: In the olfactory bulb stained 
granule cells can be seen here in the granule cell layer (GrO) and in the mitral cell layer 
(Mi). F: Stained cells in olfactory tubercle. G: Stained cells in the piriform cortex. H: 
Stained cells in the piriform cortex (Pir) can be seen here in contrast to less intense 
staining in the cortical (CA) and medial (MA) amygdaloid nuclei and very weak staining in 
the basomedial amygdaloid nucleus (BMA). I: Stained cells in the ventromedial 
hypothalamic nucleus (VM). J: Weakly stained cells in visual neocortex; the asterisk 
labels layer I of the cortex. K: Retrosplenial neocortex, with staining strongest in the 
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superficial cellular layers; the asterisk labels layer I of the cortex. L: Cerebellar cortex, 
with staining evident in both the granule cell layer (GCL) and Purkinje cell layer (PCL) but 
not in the molecular layer (ML) or white matter (WM). Abbreviations: BMA, basomedial 
amygdaloid nuclei; CA, cortical amygdaloid nuclei; DG, dentate gyrus; EPl, external 
plexiform layer of the olfactory bulb; GrDG, granule cell layer of the dentate gyrus; GrO, 
granule cell layer of the olfactory bulb; GCL, granule cell layer of the cerebellar cortex; Hi, 
hippocampus; LMol, lacunosum moleculare layer; IPl, internal plexiform layer of the 
olfactory bulb; Mi, mitral cell layer of the olfactory bulb; MA, medial amygdaloid nuclei; 
MG, medial geniculate thalamic nucleus; ML, molecular layer of the cerebellar cortex; Or, 
stratum oriens of the hippocampus; Ov, olfactory ventricle; PoDG, polymorphic layer of 
the dentate gyrus; Pir, piriform cortex; PCL, Purkinje cell layer; Py, pyramidal cell layer of 
the hippocampus; Rad, stratum radiatum of the hippocampus; Tu, olfactory tubercle; VP, 
ventral pallidum; WM, white matter. Scale bar = 50 5m in B, D, L; 100 5m in C, E, F, G, I, 
J, K; 200 5m in A, H.  
333x359mm (300 x 300 DPI)  
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Fig. 3. Characterisation of antisera (A, B, C) and affinity-purified antibodies (D, E, F) to 
mouse NAPE-PLD by Western blot analysis of brain homogenates from NAPE-PLD+/+ and 
NAPE-PLD-/- mice. NAPE-PLD antisera [A: 2282.3(AS), B: 2283.3(AS), C: 2284.3(AS)] 
label bands in wild-type (+/+) brains with a wide range of molecular masses, including 
an intensely stained band between 37 kDa and 50 kDa markers with a molecular mass 
similar to that expected for mouse NAPE-PLD (~46 kDa). However, all the stained bands 
evident in wild-type brains, including the intensely stained band between 37 kDa and 50 
kDa markers, are also detected in brains from knockout animals (-/-) and therefore are 
not NAPE-PLD, demonstrating the necessity for affinity-purification of antibodies to the 
NAPE-PLD C-terminal peptide antigen. D: Affinity-purifed antibodies derived from the 
2282.3 antiserum and eluted with glycine (G) or triethylamine (T) label a ~ 46 kDa band 
in wild-type (+/+) brain homogenates that it is not present in knockout (-/-) brain 
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homogenates and which therefore must be NAPE-PLD (see arrow). The 2282.3(G) 
antibodies also label two bands between the 25 kDa and 37 kDa markers that are present 
in both wild-type and knockout brain homogenates. However, 2282.3(T) antibodies only 
stain the ~ 46 kDa band corresponding to NAPE-PLD and therefore these antibodies were 
selected for immunocytochemical analysis of NAPE-PLD expression in mouse brain. E, F: 
Affinity-purifed antibodies derived from the 2283.3 and 2284.3 antisera also label a ~46 
kDa band corresponding to NAPE-PLD (see arrows). However, these antibodies also 
cross-react with other proteins and therefore were not used for immunocytochemical 
analysis of NAPE-PLD expression in mouse brain. 
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Fig. 4. Immunoreactivity in coronal sections of mouse forebrain (A,C,D,E,F) attributable 
to NAPE-PLD expression by comparative immunocytochemical analysis NAPE-PLD-/- mice 
(B). A: Immunostaining in anterior regions of the dentate gyrus (DG), hippocampus (Hi) 
and thalamus (MD, VTN). B: Immunostaining is almost completely absent in this coronal 
section of NAPE-PLD knockout mouse brain positioned intermediate with respect to the 
sections of wild-type brain shown in A and C. The only staining present is in ventricular 
ependyma (arrow head) and in hypothalamic magnocellular neurons (*) and, with the 
exception of these features, all of the staining in wild-type brain (A, C, D, E, F) is 
specifically attributable to NAPE-PLD expression. C, D, E, F: Here, in addition to 
immunostaining in the hippocampal formation (DG, Hi) and thalamus (Gus, LG, MD, MG, 
Po, VP), NAPE-PLD immunoreactivity is also present in the neocortex (NC), piriform 
cortex (Pir), amygdaloid complex (AmC) and hypothalamus (Hy). Abbreviations: AmC, 
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amygdaloid complex; CPu, caudate putamen; DG, dentate gyrus; Gus, gustatory thalamic 
nucleus; Hi, hippocampus; ic, internal capsule; LG, lateral geniculate thalamic nucleus; 
MD, mediodorsal thalamic nucleus; MG, medial geniculate thalamic nucleus; NC, 
neocortex; Pir, piriform cortex; Po, posterior thalamic nucleus; VP, ventroposterior 
thalamic nucleus; VTN, ventral thalamic nuclei. Scale bar = 500 5m. 
220x268mm (300 x 300 DPI)  
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Fig. 5. Localisation of NAPE-PLD immunoreactivity in mouse brain regions. A: In the 
hippocampal formation intense immunostaining is present in the polymorphic layer of the 
dentate gyrus (PoDG). Strong staining is also present in the stratum lucidum (see white 
asterisk) in the CA3 field of the hippocampus. Weaker staining is evident in the molecular 
layer of the dentate gyrus (Mol), the stratum oriens (Or) and the stratum radiatum (Rad) 
in the CA1 - CA3 fields of the hippocampus and the laterodorsal thalamic nucleus (LDTN). 
B: High magnification image showing immunostained mossy fibre axons with varicosities 
surrounding unstained cells (see asterisks) in the polymorphic layer of the dentate gyrus. 
C: Intensely immunostained mossy fibre axons can be seen here in the stratum lucidum 
(SLu) in the CA3 field of the hippocampus. Less intense staining can be seen in the 
stratum radiatum (Rad) and stratum oriens (Or). Note the absence of immunostaining in 
cell bodies of the pyramidal cell layer (Py). D: Here the intensity of immunostaining in 
hippocampal and neocortical (NC) layers can be compared; the external capsule (ec) 
marks the boundary between the neocortex and hippocampus. Note that in the molecular 
layer of the dentate gyrus (Mol) the intensity of staining in the inner zone (arrow head) is 
slightly stronger than in the outer zone of this layer. E: Immunostaining in the CA1 field 
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of the hippocampus; note that in the stratum radiatum (Rad) immunostaining surrounds 
the unstained primary dendrites of pyramidal cells. F: Immunstaining in neocortex 
(auditory); note that staining is more intense in superficial layers (Sup) of the cortex 
than in layer VI. G: Intense immunostaining is present in the vomeronasal nerve (VN) 
and its axonal projections into the glomerular layer of the accessory olfactory bulb (AOB); 
staining in lateral orbital cortex can also be seen in this image. H: Immunostaining is 
present in the olfactory nerve (ON) and the glomerular layer (Gl) of the main olfactory 
bulb but is less intense than in the vomeronasal nerve (VN); weak staining is also evident 
here in the granule cell layer of the olfactory bulb. I: Low magnification view of anterior 
forebrain showing immunostaining in cingulate (Cg) and motor (M1, M2) cortex, septum 
(S) and caudate putamen (CPu). J: In the septum immunostaining is present in the lateral 
septal nuclei (LS) but not in the medial septal nucleus (MS). K: Immunostaining in 
posterior thalamic nuclei (LG, MG, LP); note the difference in the intensity of thalamic 
staining and immunostaining in the adjacent dentate gyrus (DG). L: In the cerebellar 
cortex, very weak immunostaining is evident in the molecular layer (ML). 
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